In 2024, the National Health Service (NHS) in England faces significant challenges, with long waiting times for medical treatment leading to a concerning rise in unnecessary deaths. Reports indicate that these delays are not merely administrative issues but profoundly affecting millions of patients' health outcomes.

The Financial Times reports that the pay of the FTSE 100 chief executives has hit an average of almost £5mn after an increase of £560,000 last year. AstraZeneca boss Sir Pascal Soriot remained the best paid, with £16.9mn.